Clinical Trial Update: Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial investigating chemosensory enhancement through neuromodulation training for smell dysfunction in Long COVID, currently recruiting in Phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Olfactory Dysfunction

Snippet

Sponsor: Medical University of South Carolina | Conditions: Smell Dysfunction, Olfactory Disorder | Phase 2, Phase 3 | Status: RECRUITING